Olivia Osborn
SciClone Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Regulation of Appetite and Obesity, Immune Cell Function and Interaction, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → The cellular and signaling networks linking the immune system and metabolism in disease(2012)1,533 cited
- → Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance(2015)701 cited
- → LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes(2015)311 cited
- → Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance(2016)298 cited
- → Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer(2014)256 cited
- → Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases(2011)235 cited
- → Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction(2011)196 cited
- → Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice(2014)171 cited
- → Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity(2015)161 cited
- → Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity(2008)159 cited